Cidofovir [cidofovir]
- Terms
-
Vistide
-
1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine
1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine
Cidofovir Anhydrous
Cidofovir Sodium
Cidofovir, (+-)-isomer
Cidofovir, (R)-isomer
Cidofovir, Sodium Salt
GS 504
GS-504
HPMPC
Vistide
An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS.
- DUI
- D000077404 MeSH Browser
- CUI
- M0164905
- CAS
- Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-
- History note
- 2019 (1989)
- Public note
- 2019; CIDOFOVIR was indexed under CYTOSINE/analogs & derivatives 1989-2018; under ORGANOPHOSPHONATES 2005-2018; and under ORGANOPHOSPHORUS COMPOUNDS 1989-2004
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UR
- urine